Cape Breton Capital Group
Overview
Cape Breton Capital Group is a venture capital firm and angel group that provides equity investments and mentorship to businesses located on Cape Breton Island, Canada.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SEVO Bioscience | Sep 2026 | Angel | Lead |
| Aeon Blue | Feb 2025 | Pre Seed | Lead |
| BryoSphere Biotechnologies | Sep 2026 | Pre Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cape Breton Capital Group based?
Cape Breton Capital Group is headquartered in Sydney, Nova Scotia, Canada.
When was Cape Breton Capital Group founded?
Cape Breton Capital Group was founded in 2021.
How many portfolio companies does Cape Breton Capital Group have?
Cape Breton Capital Group has 3 portfolio companies in Caplight's dataset.
What are some companies in Cape Breton Capital Group's portfolio?
Portfolio companies visible on Caplight include SEVO Bioscience, Aeon Blue, BryoSphere Biotechnologies.
What was Cape Breton Capital Group's most recent investment shown here?
Cape Breton Capital Group's most recent investment in this portfolio sample was in SEVO Bioscience in 2026.
What sectors does Cape Breton Capital Group focus on?
Cape Breton Capital Group focuses on Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Cape Breton Capital Group focus on?
Stage focus information for Cape Breton Capital Group is not publicly available.
What is Cape Breton Capital Group's AUM?
Cape Breton Capital Group's assets under management are estimated between $1.3M and $1.5M.